Inflammation in atherosclerosis: pathophysiology and mechanisms

Area of Science:

• Cardiovascular Science
• Immunology
• Molecular Biology

Background:

• Atherosclerosis is a primary driver of cardiovascular disease (CVD), including coronary artery disease and heart failure.
• Inflammation plays a critical role in the development and progression of atherosclerotic plaques.
• Preclinical research into atherosclerotic inflammation is crucial for identifying new treatment strategies.

Purpose of the Study:

• To critically review and discuss recent molecular and cellular mechanisms of inflammation in atherosclerosis.
• To delineate signaling pathways and inflammatory responses in leukocytes that contribute to plaque inflammation.
• To highlight potential therapeutic targets and evaluate current interventions for atherosclerotic inflammation.

Main Methods:

• Literature review and critical discussion of existing research.
• Analysis of molecular and cellular mechanisms involved in inflammatory responses.
• Evaluation of signaling cascades in macrophages and leukocytes.

Main Results:

• Inflammation is central to atherosclerosis pathogenesis.
• Specific signaling cascades and leukocyte responses drive plaque inflammation.
• Novel therapeutic targets and anti-inflammatory mechanisms have been identified.

Conclusions:

• In-depth knowledge of atherosclerotic inflammation mechanisms is vital for developing novel therapies.
• Targeting inflammatory pathways in macrophages and leukocytes offers therapeutic potential.
• Further research is needed to optimize anti-inflammatory strategies for CVD prevention and treatment.